Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

NICE guidance recommends plague psoriasis treatment

  • Comment

Patients suffering severe plaque psoriasis may be offered the use of ustekinumab if they do not respond to usual therapies, according to final published guidance.

NICE has allowed adults who cannot use standard systemic therapies to be treated with the drug for a maximum of 16 weeks.

Dr Carole Longson, Health Technology Evaluation Centre Director at NICE, said: ‘Plaque psoriasis can have a huge impact on an individual, with the condition causing significant discomfort and in severe cases it can be painful.

‘The characteristic raised red patches of skin covered with silvery scales are commonly seen on elbows, knees or scalp, but in severe cases can cover most of the body.

‘This new guidance recommending ustekinumab will offer hope to adults whose severe plaque psoriasis hasn’t been helped by systemic therapies including ciclosporin, ethotrexate and psoralen with long-wave ultraviolet radiation.’

Sufferers weighing more than 100 kg will need a higher dose than lighter patients, but NICE has recommended ustekinumab on the basis that the manufacturer costs will be the same. Any sensory, learning or physical disabilities exhibited by patients should be considered by health professionals when carrying out drug response assessments.

Click here to read the guidance in full.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs